Further information concerning these requirements is found at http://grants.nih.gov/grants/policy/hs/data_safety.htm and in the application instructions (SF424 (R&R) and PHS 398). Definition and other information provided under the R13 Guidelines related links. Applicant organizations must complete and maintain the following registrations as described in the SF424 (R&R) Application Guide to be eligible to apply for or receive an award. The types of research programs we support are differentiated by NIH activity codes (e.g., R01, R43, etc.). Larger award amount than the current average NIGMS R01 award to ESIs. Study Record: PHS Human Subjects and Clinical Trials Information. Multiple PI applications have consequences worth noting for new PIs: When applying for your first independent NIH research grant, early-stage investigators get some breaks. Given that the MIRA is meant to provide support for a research program within the NIGMS mission in a PDs/PIs laboratory, and may include multiple projects on disparate topics, there is no obligation for the PD/PI to present a single unifying theme. Will address existing and future research needs in musculoskeletal, rheumatologic, and skin diseases by fostering the development, implementations, and inclusion of novel data, analytical methods, metrics, and outcome measures into clinical research at the institutional, local, and national level. Need help determining whether you are doing a clinical trial? Where necessary, PD/PIs and participants may be appropriately contacted after the completion of the grant period for updates on participants subsequent outcomes. Services, National Institutes of Health: NIGMS strongly encourages potential applicants to confer with the program officer managing awards in their specific research area at least 6 weeks prior to submission for advice on the suitability of the proposed research for NIGMS. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. You must use one of these submission PA-21-021: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed), PA-18-837: Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed), Diversity Supplement Program GuidelinesRe-Entry Supplements A K24 recipient promoted to Full Professor during the award period remains eligible to apply for a renewal application. An official website of the United States government, NINDS No Longer Participates in the Katz Program. For a complete list of NIH Request an extension to your ESI eligibility period through eRA Commons using the ESI Extension request button located in the Education section of your Personal Profile. A letter from the subcontract PD/PI should be included making it clear why they cannot participate in collaborative research with the PD/PI without support from the MIRA. The supplement may be used to support additional personnel, computational services, supplies, and equipment that will promote the continuity of the career development research project during a period in which the PD/PI experiences critical life evens which have the potential to impact research progress or potential productivity. Do not include specific aims or use any similar designation in the abstract. Is experiencing a serious personal health issue or illness and/or debilitating condition. For example, a program that by its nature is not innovative may be essential to advance a field. For projects involving key biological and/or chemical resources, reviewers will comment on the brief plans proposed for identifying and ensuring the validity of those resources. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application (see Section IV.2 SF424(R&R) Other Project Information. Email:support@grants.gov, Sailaja Koduri, Ph.D.National Institute of General Medical Sciences (NIGMS)Email: sailaja.koduri@nih.gov, Maqsood Wani, Ph.D.Center for Scientific Review (CSR)Email: wanimaqs@csr.nih.gov, Lisa MoellerNational Institute of General Medical Sciences (NIGMS)Email: moellerl@mail.nih.gov. That said, if your institution assigns you to become a principal investigator (PI) on an existing grant that you did not apply for, you still qualify as new. List the individuals/organizations with whom consortium or contractual arrangements have been made and indicate whether the collaborating institution is foreign or domestic. The ORWH promotes, stimulates, and supports efforts to improve the health of women through biomedical and behavioral research. These provide support for an investigator to collect key preliminary data in order to submit an improved revised R01 application, but you should understand that NIDDK has only enough funds to make very few of these awards. NIH separates the review process from funding decisions. If the proposed research involves human subjects and/or NIH-defined clinical research, are the plans to address: (1) the protection of human subjects from research risks, and (2) inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion or exclusion of individuals of all ages (including children and older adults), justified? This site is protected by reCAPTCHA and the GooglePrivacy Policyand Terms of Serviceapply. Applications should include a letter signed by the Institutional Business Official certifying PI's eligibility for the supplement award. See more tips for avoiding common errors. Eligible award codes include: DP1, DP2, DP5, R01, R00, R15, R34, R21 and U01. U.S. citizenship or permanent resident status is required. Any application awarded in response to this NOFO will be subject to terms and conditions found on the Award Conditions and Information for NIH Grants website. The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. Application Due Dates: Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as the PD/PI is invited to work with their organization to develop an application for support. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this NOFO. When feasible, new and early-stage investigator applications are not interspersed with those of established investigators at the review meeting and rather reviewed together as a block. As required by section 3010 of Public Law 111-212, all information posted in the designated integrity and performance system on or after April 15, 2011, except past performance reviews required for Federal procurement contracts, will be publicly available. The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. The award contains two components, a mentored (K99) phase that can last up to 2 years and an independent (R00) phase, which will have a duration of 3 years. Itemized budget information is not required and will not be accepted. Contributions to Science: This section of the biosketch should emphasize contributions over the past five years. For the purpose of the STAR Program, NIAMS defines these investigators as those who have successfully renewed a first NIAMS-supported R01 which was received no earlier than 2009 with Early Stage Investigator (ESI) status. Under these policies, an applicant's status as a new investigator is one of the criteria used in funding decisions made by the Institute. Additionally, a signed letter from the institution's Authorized Organizational Representative (AOR) stipulating to the following points will be required as just-in-time information after review for applications being considering for funding: The PD/PI will devote at least 51% of their total research effort to this award, inclusive of their combined research effort at all institutions where they hold an appointment (including foreign institutions). Other Plan(s): Note: Effective for due dates on or after January 25, 2023, the Data Management and Sharing Plan will be attached in the Other Plan(s) attachment in FORMS-H application forms packages. Each SCOR should develop an interdisciplinary research agenda bridging basic and clinical research on sex/gender factors underlying a priority womens health issue.Duration: 5 yearsBudget Cap: $750,000 direct costsApplications Due: By RFA onlyContact:NIAMSCenters Program, Minority Biomedical Research Support - MBRS. Please see https://www.hhs.gov/civil-rights/for-providers/provider-obligations/index.html and https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html. All PD(s)/PI(s) must have an eRA Commons account. Get the latest scientific news and resources on diseases of the bones, joints, muscles, and skin from the NIAMS. Is the proposed research program appropriate in scope and ambition to address the scientific questions posed? This attachment should be titled Plan for Enhancing Diverse Perspectives.. Biographical Sketches: A biosketch should only be provided for the PD/PI and, in rare cases, for collaborator(s) receiving financial support from the MIRA. All recipients of applicable NIH grants and cooperative agreementsare required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over the threshold. Information regarding the disposition of applications is available in the NIH Grants Policy Statement. Scientific and technical merit of the proposed research program as determined by scientific peer review. Where applicable, Title XI and Section 1557 prohibit discrimination on the basis of sexual orientation, and gender identity. Given that the MIRA is meant to provide support for a research program within the NIGMS mission in a PDs/PIs laboratory, and may include multiple projects on disparate topics, there is no obligation for the PD/PI to present a single unifying theme. Contact: Xibin WangApplications Due: Standard dates Additional Information: Office of Extramural Research: Small Business Innovation Research (SBIR) and Small Business Technology (STTR) Programs, Small Business Innovation Research (SBIR) Program. Applicants should directly address the rationale, underlying the balance of effort and the resources dedicated to each activity, and how the activities are distinct or complementary. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. Q7. Applications that are out of compliance with these instructions may be delayed or not accepted for review. Applications that are determined to be outside of the NIGMS mission will not be accepted for review. is acting as the primary caregiver within the first year of the birth or adoption of a child. In addition to research designed to answer scientific questions and generate new ideas and hypotheses, the development of technology and computational approaches are supported. Personal statement of the applicant, including long-term research objectives and career goals, a justification for the supplement support, and a plan to return to full productivity at the end of the supplement period. NIH staff can also help. Note that preliminary data are neither expected nor required, and PDs/PIs may wish to indicate this prominently in the Research Strategy. This document should serve both the needs of the public and the needs of the reviewers for an introduction to the research plan. While a 10-year R&R Detailed Budget form is provided in the application package, applicants may not request more than 5 years of support. First Competitive Renewal of R01 Applications From Former NIDDK ESIs NIDDK seeks to encourage the stable integration of early career researchers into the scientific research workforce. Potential applicants are strongly encouraged to discuss the suitability of the project for this program announcement with the NIAMS Program Director for that research topic area. This should be a description of the key questions or challenges the PD/PI plans to address and the general strategies that might be used to approach them. A program to invite eligible institutions to submit a pre-application (also known as a white paper or prcis) to facilitate certain approaches or economies, such as reducing burden on the applicant community, for a funding opportunity. Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars Guidelines. PHS Human Subjects and Clinical Trials Information. May I apply to another funding opportunity with the same area of research while the NIH Directors New Innovator Award is pending? NIH and NINDS want to fund early-career scientists and have special programs and funding approaches to meet that goal. A cooperative agreement research program generally involves the organized efforts of large groups, members of which are conducting research projects designed to elucidate the various aspects of a specific objective. The HHS Office for Civil Rights provides guidance on complying with civil rights laws enforced by HHS. Visit the NIH New and Early Stage Investigator Policies page, or view NIDDK Research Programs and Contacts for your scientific area of interest. Telephone: 301-402-7469 or 866-504-9552 (Toll Free), General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources) c) Under section D.2.c. Web1. Review of Applications: Has the investigator included plans to address weaknesses in the rigor of prior research that serves as the key support for the proposed research program? Award Administration Information, Maximizing Investigators' Research Award (MIRA), https://braininitiative.nih.gov/about/pedp-key-elements-and-examples, NIH Directors Transformative Research Award (TRA), Research Supplements to Promote Diversity in Health-Related Research, Research Supplement to Promote Re-Entry into Biomedical and Behavioral Research Careers, Administrative Supplements for Equipment Purchases, MIRA for Established and New Investigators, NIH Policy on Late Submission of Grant Applications, NATO Commercial and Government Entity (NCAGE) Code, Guidelines for the Review of Human Subjects, Guidelines for the Review of Inclusion in Clinical Research, Worksheet for Review of the Vertebrate Animals Section, Award Conditions and Information for NIH Grants, https://grants.nih.gov/policy/clinical-trials/reporting/index.htm, http://grants.nih.gov/grants/policy/hs/data_safety.htm, NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General, Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Recipients, and Activities, Federal wide Research Terms and Conditions, Prohibition on Certain Telecommunications and Video Surveillance Services or Equipment, HHS Assurance of Compliance form (HHS 690), https://www.hhs.gov/civil-rights/for-providers/provider-obligations/index.html, https://www.hhs.gov/civil-rights/for-individuals/nondiscrimination/index.html, https://www.hhs.gov/civil-rights/for-individuals/special-topics/limited-english-proficiency/fact-sheet-guidance/index.html, https://www.hhs.gov/civil-rights/for-individuals/disability/index.html, https://www.hhs.gov/civil-rights/for-individuals/sex-discrimination/index.html, https://grants.nih.gov/grants/policy/harassment.htm, https://www.hhs.gov/conscience/conscience-protections/index.html, https://www.hhs.gov/conscience/religious-freedom/index.html, https://www.hhs.gov/ocr/about-us/contact-us/index.html, Research Performance Progress Report (RPPR).
